MedPath

Addressing Problems in Managing Daily Tasks Due to Poststroke Cognitive Impairments

Not Applicable
Recruiting
Conditions
Cognitive Impairment
Stroke
Registration Number
NCT05829421
Lead Sponsor
Emma Ghaziani
Brief Summary

The purpose of this study is to investigate feasibility aspects of an intervention targeting problems in managing daily tasks due to mild-to-moderate poststroke cognitive impairments. We will specifically address uncertainties related to intervention content and delivery, and trial design and conduct.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
7
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Change from baseline in ADL process skills level (assessed by the Assessment of Motor and Process Skills, AMPS) at 3 months poststrokeAt baseline (as soon as possible after stroke onset - expected:1 week poststroke) and 3 months poststroke

The AMPS is a standardised observation-based instrument measuring two aspects of ADL performance: ADL motor skills (reflecting physical effort) and ADL process skills (reflecting efficiency, safety, and independence). The quality of each skill is evaluated on a 4-level scale. Based on Rasch statistics, the AMPS software converts these raw scores into two overall linear ADL scores (expressed in logits): an ADL motor score, and an ADL process score. Several studies support the AMPS' validity and reliability in both stroke populations. The AMPS is an OT-specific instrument and requires user certification.

Secondary Outcome Measures
NameTimeMethod
Change from pre-stroke in global disability (assessed by the modified Rankin Scale, mRS) at 3 months. Min-max values: 0 (no symptoms at all) - 6 (dead)At baseline (as soon as possible after stroke onset - expected:1 week poststroke) and 3 months poststroke

Stroke-specific measure of global disability. Min-max values: 0 (no symptoms at all9 - 6 (dead).

Caregiver perceived burden of stroke (assessed by the Caregiver Burden Scale, CBS) at 3 months posttsroke.At 3 months poststroke

The CBS is a 22-item scale that assess subjectively experienced burden by caregiver's to chronically disabled persons.

The caregiver is asked to tick one of the four boxes (not at all, seldom, sometimes, often) score 1 to 4 for each question.

The instrument comprises five factors: general strain, isolation, disappointment, emotional involvement and environment.

A mean value is calculated for each factor including the following items:

General strain: 1, 3, 4, 5, 7, 10, 14, and 19 Isolation: 8, 12, and 22 Disappointment: 2, 13, 18, 20, and 21 Emotional involvement: 6, 11, and 16 Environment: 9, 15, and 17

Change from baseline in ADL motor skills level (assessed by the Assessment of Motor and Process Skills, AMPS) at 3 months poststrokeAt baseline (as soon as possible after stroke onset - expected:1 week poststroke) and 3 months poststroke

The AMPS is a standardised observation-based instrument measuring two aspects of ADL performance: ADL motor skills (reflecting physical effort) and ADL process skills (reflecting efficiency, safety, and independence). The quality of each skill is evaluated on a 4-level scale. Based on Rasch statistics, the AMPS software converts these raw scores into two overall linear ADL scores (expressed in logits): an ADL motor score, and an ADL process score. Several studies support the AMPS' validity and reliability in both stroke populations. The AMPS is an OT-specific instrument and requires user certification.

Patient perceived health-related quality of life (assessed by the EuroQol-5D-5L, EQ-5D-5L) at 3 months poststrokeAt 3 months poststroke

Generic measure of health-related quality of life. It contains six subscales: mobility, self-care, usual activities, pain/discomfort, anxiety depression and perceived health. Perceived health is measured on a 0-100 scale (0: worst outcome, 100: best outcome). Each of remaining subscales are scored on a 5-level ordinal scale (1: best outcome, 5: worse outcome). The result for each subscale will be presented separately.

Trial Locations

Locations (4)

Bispebjerg and Frederiksberg Hospital

🇩🇰

Copenhagen, Denmark

Neurorehabilitation Centre Østervang

🇩🇰

Frederiksberg, Denmark

the Day Rehabilitation Centre

🇩🇰

Frederiksberg, Denmark

the Inpatient Rehabilitation Centre

🇩🇰

Frederiksberg, Denmark

Bispebjerg and Frederiksberg Hospital
🇩🇰Copenhagen, Denmark
Christian Arens, MSc
Sub Investigator
Sun-Hee Christensen, MSc
Sub Investigator
Hanne Christensen, Professor
Principal Investigator
Hana Rytter, PhD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.